A detailed history of Atom Investors LP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Atom Investors LP holds 21,315 shares of PRTA stock, worth $218,478. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,315
Holding current value
$218,478
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$6.22 - $9.76 $132,579 - $208,034
21,315 New
21,315 $208,000
Q1 2024

May 15, 2024

BUY
$24.75 - $40.66 $230,249 - $378,259
9,303 New
9,303 $230,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $481M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.